Trial intelligence / Profile preview

MSC-EXO vs PRF in Post-Extraction Socket Healing

NCT07508033Phase 2Recruiting

Sponsor
Al Salam University
Start
Jan 2026
Primary completion
Jul 2026
Modality
Lipid-based Nanoparticles
Countries
1
01

Overview

A Phase 2 trial of mesenchymal stem cell exosomes in Alveolar bone loss, sponsored by Al Salam University. Started Jan 2026; status: recruiting.

02

Drugs

mesenchymal stem cell exosomes
03

Conditions

Alveolar bone loss

Beyond the preview

Go deeper on NCT07508033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07508033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call